Many countries are now tasked with strengthening their healthcare systems and Non-Communicable Diseases (NCDs) have emerged as the primary cause of premature death and disability, affecting both industrialized and Low- and Middle-Income Countries (LMICs). Conditions such as cardiovascular diseases, cancer, diabetes, chronic respiratory conditions, and mental health disorders are increasing in prevalence, posing significant challenges for healthcare systems globally.

Addressing these challenges requires collaborative efforts to enhance regulatory frameworks, procurement processes and supply chains, to train healthcare professionals, to improve diagnostic and data capabilities, as well as to increase funding for NCDs management.

Research-based pharmaceutical companies are eager to expand existing collaborations with governments and other healthcare system’s stakeholders to improve outcomes for those living with NCDs. Collaborative examples such as “Access Accelerated”, the Ghana Heart Initiative (now called AYA), and many other public-private partnerships listed by the Global Health Progress and the WHO Knowledge Action Portal on NCDs, demonstrate the breadth and impact of these partnerships.

Strong collaboration, additional investments, and accelerated implementation of NCDs programs are crucial for achieving the health-related Sustainable Development Goals.